Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib plus methotrexate for glucocorticoid tapering in active rheumatoid arthritis
ChiCTR2000038552Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tofacitinib and methotrexate in rheumatoid arthritis (RA), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: ACR20. Started Jul 2020; status: recruiting.
02
Drugs
tofacitinibmethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR2000038552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038552.